GO:0030629 U6 snRNA 3'-end binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030629 (U6 snRNA 3'-end binding) is a molecular function describing the selective binding of proteins to the 3' terminal region of U6 small nuclear RNA.
• The human Lsm2-8 heteromer forms a doughnut-shaped ring that binds the 3' end of U6 snRNA and facilitates U4/U6 duplex formation in vitro.
• TUT1 (terminal uridylyltransferase 1) catalyzes oligouridylation of the U6 snRNA 3' end, a maturation step required for RNA splicing and stem cell survival.
• Crystal and cryo-EM structures of TUT1 and the Lsm complex bound to U6 snRNA 3' end sequences have revealed the molecular basis of 3'-end recognition.
• 3'-end-dependent formation of U6 snRNP particles was demonstrated in Xenopus laevis oocyte nuclei, establishing the 3' end as a assembly determinant.
• Dysregulation of U6 snRNA 3'-end processing factors such as TUT1 is linked to splicing defects and stem cell vulnerability, making this term relevant to cancer and RNA-processing disorders.
Description
GO:0030629, U6 snRNA 3'-end binding, is a molecular function term that describes the binding of a protein or protein complex to the 3' terminal region of U6 small nuclear RNA (U6 snRNA). U6 snRNA is a highly conserved spliceosomal RNA that undergoes extensive 3'-end processing, including oligouridylation and binding by Sm-like (Lsm) proteins, to form the mature U6 snRNP. This binding event is not merely a passive interaction; it is a prerequisite for U4/U6 duplex formation and for the subsequent catalytic steps of pre-mRNA splicing. Researchers study GO:0030629 because the 3' end of U6 snRNA serves as a platform for assembly of the U6 snRNP and for regulation of splicing activity. The human Lsm2-8 heteromer binds the 3' end of U6 snRNA and facilitates U4/U6 duplex formation in vitro, directly linking 3'-end binding to spliceosome assembly. In parallel, TUT1-catalyzed oligouridylation of the U6 snRNA 3' end is essential for RNA splicing and stem cell survival, demonstrating that 3'-end maturation and binding are tightly coupled to cell fate. From a methodological standpoint, GO:0030629 is interrogated using structural biology, RNA-protein interaction assays, and CRISPR-based perturbation of the responsible genes. The availability of crystal structures of U6 snRNA-specific terminal uridylyltransferase and of the Lsm complex bound to U6 3' end sequences provides a structural framework for interpreting functional data. This article synthesizes the QuickGO definition and verified PubMed literature to provide a research-grade overview of U6 snRNA 3'-end binding, its genes, regulation, disease links, and experimental models.
U6 snRNA 3'-end binding At A Glance
| GO ID | GO:0030629 |
|---|---|
| GO term | U6 snRNA 3'-end binding |
| Ontology | molecular_function |
| Synonym | U6 snRNA 3' end binding |
| Definition | Binding to a U6 small nuclear RNA (U6 snRNA) at the 3' end. |
| Major function | Recognition and assembly of the U6 snRNA 3' end into functional U6 snRNP complexes |
| Representative proteins | Lsm2-8 heteromer, TUT1 |
| Related process | U6 snRNA 3'-end oligouridylation and U4/U6 duplex formation |
| Experimental evidence | In vitro binding assays, crystal structures, cryo-EM, Xenopus oocyte nuclei assays |
What Is GO:0030629?
U6 snRNA 3'-end binding (GO:0030629) is the molecular function of selectively and non-covalently interacting with the 3' terminal end of U6 small nuclear RNA. This function is distinct from general RNA binding because it requires recognition of the U6 snRNA 3' end sequence and/or structure, as exemplified by the Lsm2-8 heteromer and by TUT1.
Why Is U6 snRNA 3'-end binding Important in Cell Biology?
U6 snRNA 3'-end binding is important because the 3' end of U6 snRNA is a key determinant of U6 snRNP assembly and spliceosome function. The Lsm2-8 heteromer binds the 3' end of U6 snRNA and facilitates U4/U6 duplex formation in vitro, and 3'-end-dependent formation of U6 snRNP particles has been demonstrated in Xenopus laevis oocyte nuclei. TUT1-catalyzed U6 snRNA 3'-end maturation is essential for RNA splicing and stem cell survival, indicating that defects in this binding/maturation axis can impair splicing and compromise stem cell maintenance. Therefore, GO:0030629 is central to understanding how splicing fidelity and stem cell viability are maintained.
• Defines a specific RNA-protein interaction required for U6 snRNP assembly.
• Facilitates U4/U6 duplex formation, a prerequisite for spliceosome activation.
• Coupled to TUT1-mediated oligouridylation, a maturation step essential for splicing.
• Required for stem cell survival, linking 3'-end binding to cell fate decisions.
• Provides a structural paradigm for Lsm-RNA recognition via crystal structures.
• Provides a structural paradigm for TUT1-RNA recognition via crystal and cryo-EM structures.
• Relevant to cancer and RNA-processing disorders through splicing dysregulation.
• Enables CRISPR-based functional dissection of U6 3'-end binding factors.
• Supports development of RNA-protein interaction inhibitors targeting splicing.
• Informs models of U6 snRNA biogenesis and turnover.
Molecular Mechanism of U6 snRNA 3'-end binding
Recognition of the U6 snRNA 3' end by the Lsm2-8 heteromer
In simple terms: A ring of proteins clamps onto the tail end of U6 snRNA.
The human Lsm2-8 heteromer forms a doughnut-shaped ring that binds the 3' end of U6 snRNA, thereby facilitating U4/U6 duplex formation in vitro. Crystal structures of the Lsm complex bound to the 3' end sequence of U6 small nuclear RNA revealed the structural basis for this sequence-specific recognition. This binding event is a defined molecular function corresponding to GO:0030629.
TUT1-catalyzed oligouridylation of the U6 snRNA 3' end
In simple terms: An enzyme adds a short tail of U's to the end of U6 snRNA.
TUT1 is a U6 snRNA-specific terminal uridylyltransferase that catalyzes oligouridylation of the U6 snRNA 3' end. Crystal structures of U6 snRNA-specific terminal uridylyltransferase provided insight into how TUT1 recognizes its RNA substrate, and a cryo-EM structure of the human TUT1:U6 snRNA complex further defined the interaction. TUT1-catalyzed U6 snRNA 3'-end maturation is essential for RNA splicing and stem cell survival.
3'-end-dependent formation of U6 snRNP particles
In simple terms: The tail end of U6 snRNA is needed to build the U6 snRNP particle.
In Xenopus laevis oocyte nuclei, formation of U6 small nuclear ribonucleoprotein particles is 3'-end-dependent. This established that the 3' end of U6 snRNA is not dispensable but serves as a assembly determinant for U6 snRNP. The function GO:0030629 captures the binding event that underlies this assembly step.
Coupling of 3'-end binding to U4/U6 duplex formation
In simple terms: Once proteins grab the U6 tail, U6 can pair with U4.
Binding of the Lsm2-8 heteromer to the 3' end of U6 snRNA facilitates U4/U6 duplex formation in vitro. This links GO:0030629 directly to a downstream spliceosomal assembly step. The structural data on Lsm-U6 3' end recognition provide a mechanistic explanation for this facilitation.
Regulation of U6 snRNA 3'-end processing and binding
In simple terms: Cells control how much U6 tail is added and when.
Function and regulation of human terminal uridylyltransferases, including TUT1, have been reviewed in the context of U6 snRNA 3'-end processing. TUT1-catalyzed U6 snRNA 3'-end maturation is essential for RNA splicing and stem cell survival, indicating that this step is under functional constraint. The interplay between oligouridylation and Lsm binding defines the mature 3' end state recognized by GO:0030629.
Key Genes Involved in GO:0030629 U6 snRNA 3'-end binding
The following genes and protein complexes are experimentally implicated in U6 snRNA 3'-end binding or its coupled 3'-end maturation steps.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TUT1 | U6 snRNA-specific terminal uridylyltransferase that oligouridylates the U6 3' end | Essential for U6 3'-end maturation, splicing, and stem cell survival |
| LSM2 | Component of the Lsm2-8 heteromer that binds the U6 snRNA 3' end | Facilitates U4/U6 duplex formation in vitro |
| LSM3 | Component of the Lsm2-8 heteromer | Structural determinant of U6 3'-end recognition |
| LSM4 | Component of the Lsm2-8 heteromer | Contributes to doughnut-shaped ring assembly |
| LSM5 | Component of the Lsm2-8 heteromer | Required for U6 3'-end binding activity |
| LSM6 | Component of the Lsm2-8 heteromer | Part of the U6 snRNA 3'-end binding platform |
| LSM7 | Component of the Lsm2-8 heteromer | Contributes to U4/U6 duplex formation |
| LSM8 | Component of the Lsm2-8 heteromer | Completes the Lsm ring that binds U6 3' end |
| U6 snRNA (RNU6) | The RNA substrate whose 3' end is bound | Central entity of GO:0030629 |
| U4 snRNA (RNU4) | Pairs with U6 to form U4/U6 duplex | Downstream readout of U6 3'-end binding |
| PRPF8 | Spliceosomal protein associated with U6 snRNP function | Context for splicing defects upon U6 3'-end perturbation |
| SNRNP200 | Spliceosomal helicase involved in U4/U6 unwinding | Downstream of U4/U6 duplex formation |
| TUT4 | Related terminal uridylyltransferase family member | Comparative studies of uridylyltransferase specificity |
| TUT7 | Related terminal uridylyltransferase family member | Comparative studies of uridylyltransferase specificity |
| LSm1-7 complex | Cytoplasmic Lsm complex related to Lsm2-8 | Structural and functional comparison with U6-binding Lsm2-8 |
| SMN1 | SMN complex involved in snRNP assembly | Context for U6 snRNP assembly studies |
| Xenopus U6 snRNA | Model RNA for 3'-end-dependent U6 snRNP formation | Oocyte nuclei assay system |
How Is U6 snRNA 3'-end binding Regulated?
Regulation of U6 snRNA 3'-end binding is coupled to the enzymatic activity of terminal uridylyltransferases and to the availability of Lsm proteins. TUT1 catalyzes oligouridylation of the U6 snRNA 3' end, and this maturation step is essential for RNA splicing and stem cell survival. The function and regulation of human terminal uridylyltransferases have been reviewed, highlighting that U6 snRNA 3'-end processing is a controlled step. Binding of the Lsm2-8 heteromer to the U6 3' end facilitates U4/U6 duplex formation, suggesting that Lsm availability and RNA modification status jointly regulate this molecular function.
U6 snRNA 3'-end binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TUT1 | Splicing defects and stem cell vulnerability | TUT1 knockout and point-mutation cell models |
| LSM2 | Spliceosome assembly defects | LSM2 knockout with U6 3'-end binding assays |
| LSM4 | U4/U6 duplex formation defects | LSM4 knockout and rescue with wild-type or mutant LSM4 |
| LSM8 | U6 snRNP assembly defects | LSM8 knockout and structural complementation |
| U6 snRNA (RNU6) | Splicing dysfunction | U6 3'-end mutant knock-in models |
Splicing defects and stem cell vulnerability
TUT1-catalyzed U6 snRNA 3'-end maturation is essential for RNA splicing and stem cell survival. Perturbation of this pathway impairs splicing and compromises stem cell maintenance, linking GO:0030629 to diseases characterized by splicing dysfunction and stem cell loss. Because U6 snRNA 3'-end binding is coupled to oligouridylation, defects in either step can converge on splicing failure.
Cancer and RNA-processing disorders
Dysregulation of terminal uridylyltransferases, including TUT1, has been discussed in the context of human disease and RNA processing. Since U6 snRNA 3'-end binding is required for U4/U6 duplex formation and spliceosome assembly, its disruption may contribute to aberrant splicing observed in cancer and other RNA-processing disorders. The structural and functional data on Lsm-U6 and TUT1-U6 complexes provide a basis for targeting these interactions.
Developmental and tissue-specific roles
The requirement for TUT1-catalyzed U6 snRNA 3'-end maturation in stem cell survival suggests developmental and tissue-specific roles for this pathway. 3'-end-dependent formation of U6 snRNP particles in Xenopus laevis oocyte nuclei indicates that this function is conserved in vertebrate development. These observations position GO:0030629 as a potential node in developmental splicing programs.
From U6 snRNA 3'-end binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is TUT1 required for U6 snRNA 3'-end maturation and splicing? | TUT1 knockout cell line with RNA-seq and U6 3'-end assays |
| Does Lsm2-8 binding to U6 3' end require specific residues? | Point-mutation knock-in of LSM genes with in vitro binding assays |
| Can wild-type TUT1 rescue splicing defects? | Knock-in of tagged TUT1 and rescue experiments |
| What is the structural basis of TUT1-U6 recognition? | Cryo-EM and crystallography of TUT1:U6 snRNA complex |
| How does U6 3'-end binding affect U4/U6 duplex formation? | In vitro duplex formation assays with purified Lsm2-8 |
| Is U6 snRNP assembly 3'-end-dependent in vivo? | Xenopus laevis oocyte nuclei injection assays |
How to Study the U6 snRNA 3'-end binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Electrophoretic mobility shift assay (EMSA) | Direct binding of proteins to U6 snRNA 3' end | Testing Lsm2-8 or TUT1 binding to U6 3' end fragments |
| Crystallography | Atomic structure of protein-RNA complexes | Defining U6 3'-end recognition by Lsm and TUT1 |
| Cryo-EM | Structure of large TUT1:U6 snRNA complex | Visualizing dynamic RNA-protein interfaces |
| Xenopus oocyte nuclei injection | U6 snRNP assembly in vivo-like system | Testing 3'-end dependence of U6 snRNP formation |
| RNA-seq | Transcriptome-wide splicing changes | Assessing consequences of TUT1 loss |
| CRISPR knockout | Gene function loss | Perturbing TUT1 or LSM genes |
| In vitro uridylylation assay | TUT1 catalytic activity on U6 3' end | Measuring oligouridylation |
| U4/U6 duplex formation assay | Duplex assembly efficiency | Testing functional consequence of 3'-end binding |
RNA-protein binding assays
In vitro binding assays using purified Lsm2-8 heteromer and U6 snRNA 3' end fragments were used to demonstrate 3'-end binding and facilitation of U4/U6 duplex formation. Such assays remain the primary method to measure GO:0030629 activity directly.
Structural biology (crystallography and cryo-EM)
Crystal structures of U6 snRNA-specific terminal uridylyltransferase and of the Lsm complex bound to the U6 3' end sequence provided atomic-level views of 3'-end recognition. A cryo-EM structure of the human TUT1:U6 snRNA complex further defined the interaction interface.
Xenopus oocyte nuclei assays
3'-end-dependent formation of U6 small nuclear ribonucleoprotein particles was demonstrated in Xenopus laevis oocyte nuclei, providing an in vivo-like system for studying U6 snRNP assembly.
CRISPR perturbation and RNA-seq
CRISPR-based knockout of TUT1 and subsequent RNA-seq revealed that TUT1-catalyzed U6 snRNA 3'-end maturation is essential for RNA splicing and stem cell survival. This approach links loss of GO:0030629-related activity to transcriptome-wide splicing changes.
How CRISPR Can Be Used to Study GO:0030629 U6 snRNA 3'-end binding
Knockout
CRISPR knockout of TUT1 has been used to demonstrate that TUT1-catalyzed U6 snRNA 3'-end maturation is essential for RNA splicing and stem cell survival. Knockout of LSM genes can be used to test the requirement for the Lsm2-8 heteromer in U6 3'-end binding and U4/U6 duplex formation.
Point Mutation
Point mutations in LSM genes or in the U6 snRNA 3' end sequence can be introduced to map residues required for binding, guided by crystal structures of the Lsm complex bound to U6 3' end. Point mutations in TUT1 can be designed based on crystal and cryo-EM structures to separate catalytic activity from RNA binding.
Knock-in
Knock-in of tagged TUT1 or LSM alleles allows affinity purification and localization studies of the U6 3'-end binding machinery. Knock-in of mutant U6 snRNA 3' ends can test the sequence requirements for U6 snRNP assembly.
Overexpression
Overexpression of TUT1 or Lsm subunits can be used to test whether excess 3'-end binding activity alters U4/U6 duplex formation or splicing. Overexpression models complement loss-of-function studies and help define dose-dependent effects on GO:0030629.
How EDITGENE Supports U6 snRNA 3'-end binding Research
Researchers studying U6 snRNA 3'-end binding-related genes often need to determine whether a candidate gene is causally involved in U6 snRNP assembly, splicing, or stem cell survival. EDITGENE provides CRISPR-based cell model services that enable precise perturbation of TUT1, LSM genes, and U6 snRNA 3' end sequences to test such hypotheses.
Contact EDITGENE today to design your custom CRISPR model for U6 snRNA 3'-end binding research.
Frequently Asked Questions About U6 snRNA 3'-end binding
What is U6 snRNA 3'-end binding?
U6 snRNA 3'-end binding (GO:0030629) is the molecular function of binding to the 3' end of U6 small nuclear RNA, as defined by QuickGO and supported by studies of the Lsm2-8 heteromer and TUT1.
What genes are involved in U6 snRNA 3'-end binding?
Key genes include TUT1, which oligouridylates the U6 3' end, and LSM2-LSM8, which form the Lsm2-8 heteromer that binds the U6 3' end.
What is the GO ID for U6 snRNA 3'-end binding?
The GO ID is GO:0030629, with the synonym U6 snRNA 3' end binding.
How does the Lsm complex bind U6 snRNA?
The human Lsm2-8 heteromer forms a doughnut-shaped ring that binds the 3' end of U6 snRNA and facilitates U4/U6 duplex formation in vitro.
What does TUT1 do to U6 snRNA?
TUT1 is a U6 snRNA-specific terminal uridylyltransferase that catalyzes oligouridylation of the U6 snRNA 3' end, a step essential for RNA splicing and stem cell survival.
Why is U6 snRNA 3'-end binding important for splicing?
Binding of Lsm2-8 to the U6 3' end facilitates U4/U6 duplex formation, a prerequisite for spliceosome activation.
Is U6 snRNP assembly dependent on the 3' end?
Yes, 3'-end-dependent formation of U6 small nuclear ribonucleoprotein particles was demonstrated in Xenopus laevis oocyte nuclei.
What diseases are linked to U6 snRNA 3'-end binding defects?
Defects in TUT1-catalyzed U6 3'-end maturation impair splicing and stem cell survival, linking this pathway to splicing-related diseases and cancer.
What methods are used to study U6 snRNA 3'-end binding?
Common methods include EMSA, crystallography, cryo-EM, Xenopus oocyte nuclei assays, RNA-seq, and CRISPR knockout.
Can CRISPR be used to study U6 snRNA 3'-end binding?
Yes, CRISPR knockout of TUT1 and LSM genes, as well as point-mutation and knock-in models, can be used to dissect this function.
Conclusion
GO:0030629, U6 snRNA 3'-end binding, is a molecular function that connects the 3' terminal region of U6 snRNA to spliceosome assembly and stem cell survival. The Lsm2-8 heteromer and TUT1 are the best-characterized factors mediating this function, with structural and functional evidence from crystallography, cryo-EM, and in vitro binding assays. Because U6 snRNA 3'-end maturation is essential for RNA splicing and stem cell survival, this term is relevant to splicing-related diseases and cancer. CRISPR-based knockout, point-mutation, knock-in, and overexpression models provide a direct route to test causality and to identify modifiers of this pathway.
References
- 1. Fang Y et al.. 2026. TUT1-catalyzed U6 snRNA 3'-end maturation is essential for RNA splicing and stem cell survival.. EMBO Rep 27(10):2703-2730 PMID: 41957187
- 2. Yamashita S et al.. 2023. Mechanism of U6 snRNA oligouridylation by human TUT1.. Nat Commun 14(1):4686 PMID: 37563152
- 3. Achsel T et al.. 1999. A doughnut-shaped heteromer of human Sm-like proteins binds to the 3'-end of U6 snRNA, thereby facilitating U4/U6 duplex formation in vitro.. EMBO J 18(20):5789-802 PMID: 10523320
- 4. Terns MP et al.. 1992. 3'-end-dependent formation of U6 small nuclear ribonucleoprotein particles in Xenopus laevis oocyte nuclei.. Mol Cell Biol 12(7):3032-40 PMID: 1535684
- 5. Yashiro Y et al.. 2018. Function and Regulation of Human Terminal Uridylyltransferases.. Front Genet 9:538 PMID: 30483311
- 6. Yamashita S et al.. 2017. Crystal structures of U6 snRNA-specific terminal uridylyltransferase.. Nat Commun 8:15788 PMID: 28589955
- 7. Yamashita S et al.. 2025. Cryo-EM structure of human TUT1:U6 snRNA complex.. Nucleic Acids Res 53(2) PMID: 39831302
- 8. Zhou L et al.. 2014. Crystal structures of the Lsm complex bound to the 3' end sequence of U6 small nuclear RNA.. Nature 506(7486):116-20 PMID: 24240276
